Skip to main content
AARD logo

Aardvark Therapeutics, Inc.

AARDNASDAQHealthcareBiotechnology

$3.80Today:- (-)1Y −69.87%

As of Oct 16, 2026 close

Market cap
$84.33M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.35$16.60
Volume (live)
-
Avg. volume (3M)
127.78K

Aardvark Therapeutics, Inc. (AARD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Aardvark Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Hold
Based on 7 unique analysts
Medium Confidence0.5:1 Buy/Sell

Average Price Target

$5.25
+38.16% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AARD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Brian Abrahams
RBC Capital
HoldMaintains
$6.00
Tazeen Ahmad
BofA Securities
SellMaintains
-
James Condulis
Stifel Nicolaus
HoldReiterates
$6.00
Jeet Mukherjee
BTIG
HoldMaintains
-
Andy Hsieh
William Blair
BuyReiterates
-
Michael Ulz
Morgan Stanley
SellReiterates
$3.00
Ram Selvaraju
HC Wainwright
HoldReiterates
$6.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 24, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AARD?

The analyst consensus rating for AARD is Hold, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for AARD?

The average 12-month price target for AARD is $5.25, representing an upside of 38.2% from the Oct 16, 2026 close of $3.80.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.